|
|
News for Healthier Living
FDA Clears Blood Test to Aid Evaluation for Alzheimer's Disease
The FDA has cleared a blood test developed from technology invented at WashU Medicine to aid in diagnosing Alzheimer's disease. The test, PrecivityAD2, can detect amyloid plaque biomarkers with over 90% accuracy, offering a less invasive alternative to spinal taps and brain scans.
August 21, 2026
August 26 2026August 25 2026August 24 2026August 21 2026August 20 2026August 19 2026August 18 2026August 17 2026August 16 2026August 15 2026August 14 2026August 13 2026August 12 2026
|
|
|
|
|